Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv



CE Mark Approved for Boston Scientific’s Agent PTCA Balloon

July 23, 2014—Boston Scientific Corporation announced the CE Mark approval and European launch of the Agent paclitaxel-coated percutaneous transluminal coronary angiopla…

Boston Scientific Launches Polaris Imaging System

July 22, 2014—Boston Scientific Corporation announced the full commercial launch of the Polaris imaging system that will support the company’s family of intravascu…

Miracor Launches Next-Generation PICSO Impulse System in Europe

July 22, 2014—Miracor Medical Systems announced the launch of its next-generation PICSO Impulse system for the treatment of myocardial infarction. The new PICSO (pressur…

FDA Approves Boston Scientific’s Bare-Metal Rebel PtCr Coronary Stent System

July 21, 2014—Boston Scientific Corporation announced that the bare-metal Rebel platinum chromium (PtCr) coronary stent system has received US Food and Drug Administrati…

Early and Midterm Data From GHOST-EU Registry Published

July 18, 2014—EuroIntervention Editor-in-Chief Patrick Serruys, MD, announced the publication of the early and midterm outcomes of GHOST-EU, the largest (N = 1,189) Euro…

Long-Term Follow-Up Published on Elective CTO PCI From the UK Central Cardiac Audit Database

July 14, 2014—Long-term follow-up findings on elective treatment of coronary chronic total occlusions (CTOs) from the UK Central Cardiac Audit database (CCAD) were publi…

Boston Scientific Receives CE Mark Approval for 25-mm Lotus TAVR System

July 14, 2014—Boston Scientific Corporation announced that it has received European CE Mark approval for the 25-mm Lotus transcatheter aortic valve replacement (TAVR) sy…

physician counsel

What's Lurking in Your Industry Contracts?

Factors to consider before signing your next consulting agreement.

I Object! Questions Facing Physicians’ Rights to Dispute Sunshine Data

Will your practice be prepared when CMS posts Sunshine disclosures later this year?

Who Just Got Paid?

A fictional account representing physicians’ common concerns and how to communicate with your industry contacts to ensure reported payments are properly perceived by the public.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




2014 Buyer’s Guide


This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.

Website Design by Sides Media